Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mintech-Bio is a clinical-stage biotechnology company specializing in regenerative dental medicine and enamel restoration. Utilizing a proprietary platform based on epitaxial growth and biomimetic crystals, the company develops therapies that re-mineralize tooth enamel and dentin to treat conditions such as irreversible enamel loss, tooth sensitivity, and white spot lesions. Its lead product, Epinamel, is designed to integrate with the natural architecture of the tooth, providing a functional and aesthetic restoration that resists bacterial biofilm formation. Founded in 2022 and headquartered in Florida, Mintech-Bio is advancing a pipeline of mineralizing gels and serums aimed at transforming oral healthcare through advanced biomaterials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mintech.